Therefore, we infer that Shionone protects against to AKI by inhibiting ECM1, which activates GM-CSF/STAT5/Arg1 to promote M2 macrophages on the one hand, and reduces M1 macrophages on the other, which reduces inflammation and promotes tissue repair. This evidence concerns the gene ECM1 and acute kidney injury.